2 completed, 1 active not recruiting, 1 not yet recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Not yet recruiting 1 |
Follow Lichen Sclerosus et Atrophicus: new trials by email Literature Review of Lichen Sclerosus et Atrophicus trials Research Report on Lichen Sclerosus et Atrophicus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nemolizumab for LS Nemolizumab 30 mg - Lichen Sclerosus of Vulva | Phase 2 | Not yet recruiting | University of Texas Southwestern Medical Center | 25 | 2026-09-01 | 2026-07-15 |
| Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation Ruxolitinib Topical Cream - Immune-related Vitiligo-like-Depigmentation | Phase 2 | Active not recruiting | University of Zurich | 34 | 2024-07-25 | 2026-07-24 |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus Ruxolitinib cream, Vehicle cream - Lichen Sclerosus | Phase 2 | Completed | Incyte Corporation | 61 | 2022-11-18 | 2024-09-24 |
| Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus pimecrolimus and clobetasol, clobetasol 0.05% cream - Lichen Sclerosus | Phase 2 | Completed | Center for Vulvovaginal Disorders | 38 | 2006-10-01 | 2014-05-12 |
Skin Diseases (1) · Vitiligo (1) · Vulvar Diseases (1) · Vulvar Lichen Sclerosus (1)
Lichenoid Eruptions (4) · Skin Diseases, Papulosquamous (4) · Skin and Connective Tissue Diseases (4) · Skin Diseases (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Urogenital Diseases (2) · Hypopigmentation (1) · Pigmentation Disorders (1) · Vulvar Diseases (1)
Clobetasol (1) · nemolizumab (1) · pimecrolimus (1) · ruxolitinib (1)
Center for Vulvovaginal Disorders (1) · Incyte Corporation (1) · University of Texas Southwestern Medical Center (1) · University of Zurich (1)
United States (3) · Canada (1) · Switzerland (1)
Andrew T Goldstein, MD (1) · Haq Nawaz, MD (1) · Melissa Mauskar, MD (1)
2023 (1)